ScholarIQanswers from OpenAlex
Diabetes, Cardiovascular Risks, and Lipoproteins
TopicLeading institutions, researchers & key papers
Diabetes, Cardiovascular Risks, and Lipoproteins is a topic indexed in ScholarIQ from OpenAlex.
What is known about Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQrecord summary
This cluster of papers focuses on the metabolic syndrome, its association with cardiovascular disease, diabetes, insulin resistance, obesity, and atherosclerosis. It includes studies on glucose metabolism, lifestyle interventions, and global prevalence of related conditions.
How many works does Diabetes, Cardiovascular Risks, and Lipoproteins have?
ScholarIQindexed works
Diabetes, Cardiovascular Risks, and Lipoproteins has 105,771 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Diabetes, Cardiovascular Risks, and Lipoproteins have?
ScholarIQcitation count
Diabetes, Cardiovascular Risks, and Lipoproteins has 2,856,613 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQopenalex
The OpenAlex for Diabetes, Cardiovascular Risks, and Lipoproteins is on the source record.
Who are the most-cited researchers behind Diabetes, Cardiovascular Risks, and Lipoproteins?
ScholarIQtop researchers by citations
Where is Diabetes, Cardiovascular Risks, and Lipoproteins research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
No journal data available yet.
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock